New osteoporosis drug copycat tested in healthy volunteers
NCT ID NCT07384104
First seen Feb 03, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study compares a new experimental drug, SAL023, to an approved osteoporosis medicine called Evenity. It involves 118 healthy Chinese adults aged 18 to 45. The goal is to see if the new drug works similarly in the body and is as safe as the approved one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Hospital of Anhui Medical University Clinical Pharmacology Research Center
Hefei, Anhui, 230601, China
Conditions
Explore the condition pages connected to this study.